A new, rapid testing method will greatly help the diagnosis of rare diseases in babies and children, according to research ...

While genetic testing has advanced, and has enabled clinicians and doctors to provide families with answers when medical problems arise in children... | Clinical And Molecular Dx ...

Two Molecular Residual Disease (MRD) studies highlighting clinical data among seven new studies to be shared by Myriad and ...

Myriad Genetics, Inc. (NASDAQ:MYGN) is making waves at the 2025 ASCO Annual Meeting, presenting seven new research studies ...

“Our new test can identify more than 8,000 proteins in peripheral blood mononuclear cells (PBMCs) covering more than 50 per ...

The global transplant diagnostics market is projected to grow at a CAGR of 6-8% over the next 5 years. The increasing ...

Scientists and medics have developed an ultra-rapid method of genetically diagnosing brain tumors that will cut the time it takes to classify them from 6-8 weeks, to as little as two hours.The team ...

The DNA polymerase market is poised for steady growth, with a projected CAGR of 6-8% over the forecast period, driven by ...

A new study reveals that over one in four Indian children under 12 carry inherited blood disorders. The findings highlight ...

Scientists have developed a rapid test that uses genetic tools to diagnose brain tumors. This method can reduce the diagnostic process down... | Clinical And Molecular Dx ...

With gene therapy offering new hope for thalassemia, experts urge Indian govt to invest in early diagnosis, genetic testing, ...